34 related articles for article (PubMed ID: 26916445)
1. Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison.
Eisengart JB; Rudser KD; Xue Y; Orchard P; Miller W; Lund T; Van der Ploeg A; Mercer J; Jones S; Mengel KE; Gökce S; Guffon N; Giugliani R; de Souza CFM; Shapiro EG; Whitley CB
Genet Med; 2018 Nov; 20(11):1423-1429. PubMed ID: 29517765
[TBL] [Abstract][Full Text] [Related]
2. Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS).
Spataro F; Viggiani F; Macchia DG; Rollo V; Tummolo A; Suppressa P; Sabba' C; Rossi MP; Giliberti L; Satriano F; Nettis E; Di Bona D; Caiaffa MF; Fischetto R; Macchia L
Orphanet J Rare Dis; 2022 Nov; 17(1):402. PubMed ID: 36329518
[TBL] [Abstract][Full Text] [Related]
3. Laronidase hypersensitivity and desensitization in type I mucopolysaccharidosis: a case report.
Ensina LF; Aranda CS; de Lacerda AE; Camelo-Nunes I; Sole D; Martins AM; Castells M
Pediatr Allergy Immunol; 2014 Aug; 25(5):498-9. PubMed ID: 25313426
[No Abstract] [Full Text] [Related]
4. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).
Wraith JE; Beck M; Lane R; van der Ploeg A; Shapiro E; Xue Y; Kakkis ED; Guffon N
Pediatrics; 2007 Jul; 120(1):e37-46. PubMed ID: 17606547
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation.
Polgreen LE; Lund TC; Braunlin E; Tolar J; Miller BS; Fung E; Whitley CB; Eisengart JB; Northrop E; Rudser K; Miller WP; Orchard PJ
Pediatr Res; 2020 Jan; 87(1):104-111. PubMed ID: 31434105
[TBL] [Abstract][Full Text] [Related]
6. Laronidase desensitization during stem cell transplant in a child with Hurler syndrome.
Rosenberg J; Jhaveri P; Kelbel T
Ann Allergy Asthma Immunol; 2016 Apr; 116(4):377-8. PubMed ID: 26916445
[No Abstract] [Full Text] [Related]
7. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
Jameson E; Jones S; Remmington T
Cochrane Database Syst Rev; 2016 Apr; 4():CD009354. PubMed ID: 27033167
[TBL] [Abstract][Full Text] [Related]
8. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
Jameson E; Jones S; Wraith JE
Cochrane Database Syst Rev; 2013 Nov; (11):CD009354. PubMed ID: 24257962
[TBL] [Abstract][Full Text] [Related]
9. Mucopolysaccharidosis type I.
Wraith JE; Jones S
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
[TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement therapy for the management of the mucopolysaccharidoses.
Wraith JE
Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S63-5. PubMed ID: 20040314
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
